A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma
Status:
Recruiting
Trial end date:
2022-04-25
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to demonstrate that dupilumab treatment improves
exercise capacity in patients with moderate-to-severe asthma.
The secondary objectives of the study are:
- To demonstrate that dupilumab treatment increases physical activity of daily living in
patients with moderate-to-severe asthma
- To demonstrate that dupilumab treatment improves pre- and post-exercise lung function in
patients with moderate-to-severe asthma